James Andrew Lawrence Brown (James Al Brown, J A L Brown, J A Brown, James A L Brown)

Scopus Author ID Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 15

Top Venues

Cancers

Epigenomics

BMC cancer

Pharmaceutical patent analyst

University of Limerick

Queensland University of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Limerick

Iceland

Lecturer Cell Biology/Immunology/PI :: Biological Sciences

National University of Ireland - Galway

Ireland

Lecturer :: Surgery

National University of Ireland - Galway

Ireland

Honorary Research Lecturer :: Medicine

National University of Ireland - Galway Mar 01 2014

Ireland

Postdoctoral Fellow :: Medicine

Education History

Queensland University of Technology

Australia

PHD :: Biochemistry

Publications

Nazanin Zohourian, James Andrew Lawrence Brown
Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics. Epigenomics (2024)
Nazanin Zohourian, Erin Coll, Muiread Dever, Anna Sheahan, Petra Burns-Lane, James Andrew Lawrence Brown
Evaluating the Cellular Roles of the Lysine Acetyltransferase Tip60 in Cancer: A Multi-Action Molecular Target for Precision Oncology. Cancers 16 (15) (2024)
Nazanin Zohourian, James Andrew Lawrence Brown
Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics. Epigenomics (2024)
Nazanin Zohourian, James Andrew Lawrence Brown
Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics. Epigenomics (2024)
Nazanin Zohourian, Erin Coll, Muiread Dever, Anna Sheahan, Petra Burns-Lane, James Andrew Lawrence Brown
Evaluating the Cellular Roles of the Lysine Acetyltransferase Tip60 in Cancer: A Multi-Action Molecular Target for Precision Oncology. Cancers 16 (15) (2024)
James Andrew Lawrence Brown
Profiling leadership: Attitudes, knowledge and training in the biological sciences. PloS one 18 (6) (2023)
James Andrew Lawrence Brown, Emer Bourke, W W Hancock, D J Richard
Editorial: Mechanisms guarding the genome. Frontiers in cell and developmental biology 10 (2022)
Andrew McGuire, Maire-Caitlin Casey, Ronan M Waldron, Helen Heneghan, Olga Kalinina, Emma Holian, Ailbhe McDermott, Aoife J Lowery, John Newell, Róisín M Dwyer, Nicola Miller, Maccon Keane, James Andrew Lawrence Brown, Michael J Kerin
Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers 12 (7) (2020)
James Andrew Lawrence Brown
Patent spotlight: small-molecule lysine acetyltransferase inhibitors (KATi). Pharmaceutical patent analyst 9 (1) (2020)
Peter McAnena, Kahraman Tanriverdi, Catherine Curran, K Gilligan, Jane E Freedman, James Andrew Lawrence Brown, Michael J Kerin
Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer. BMC cancer 19 (1) (2019)
M C Casey, A Prakash, E Holian, A McGuire, O Kalinina, A Shalaby, C Curran, M Webber, G Callagy, E Bourke, M J Kerin, James Andrew Lawrence Brown
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer. BMC cancer 19 (1) (2019)
A McGuire, M C Casey, A Shalaby, O Kalinina, C Curran, M Webber, G Callagy, E Holian, E Bourke, M J Kerin, James Andrew Lawrence Brown
Quantifying Tip60 (Kat5) stratifies breast cancer. Scientific reports 9 (1) (2019)
Anu Prakash, Juan F Garcia-Moreno, James Andrew Lawrence Brown, Emer Bourke
Clinically Applicable Inhibitors Impacting Genome Stability. Molecules (Basel, Switzerland) 23 (5) (2018)
Andrew McGuire, Olga Kalinina, Emma Holian, Catherine Curran, Carmel A Malone, Ray McLaughlin, Aoife Lowery, James Andrew Lawrence Brown, Michael J Kerin
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab. Breast cancer research and treatment 164 (1) (2017)
Máire-Caitlín Casey, Karl J Sweeney, James Andrew Lawrence Brown, Michael J Kerin
Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer. International journal of cancer 139 (1) (2016)

James Andrew Lawrence Brown.css-eqlu8i{font-size:small;padding-left:4px;} (James Al Brown, J A L Brown, J A Brown, James A L Brown)

Publication Activity (10 Years)

Top Topics

Top Venues

James Andrew Lawrence Brown (James Al Brown, J A L Brown, J A Brown, James A L Brown)